Table 4 Proportion (%) of those patients reaching targets in primary end points among those exceeding these values at baseline in the analysed population (intervention = 816, controls = 405)
Type 2 Diabetes | Coronary artery disease | Congestive heart failure | ||||
|---|---|---|---|---|---|---|
Intervention | Control | Intervention | Control | Intervention | Control | |
Hb1Ac (<7%) | 30.2% (n=65/215) | 29.7% (n=27/91) | ||||
Waist circumference (<90cm women, <100cm men) | 9.8% (n=46/470) | 5.1% (n=12/234) | 11.1% (n=8/72) | 9.5% (n=4/42) | 10.8% (n=4/37) | 15.8% (n=3/19) |
Systolic blood pressure (<140mmHg) | 32.7% (n=107/327) | 35.8% (n=53/148) | 47.1% (n=24/51) | 16.1% (n=5/31) | 60.0% (n=12/20) | 0% (n=0/8) |
Diastolic blood pressure (<85mmHg) | 45.5% (n=120/264) | 37.7% (n=49/130) | 56.4% (n=22/39) | 26.1% (n=6/23) | 66.7% (n=14/21) | 53.8% (n=7/13) |
Serum total cholesterol (<4.5mmol/l) | 30.7% (n=23/75) | 35.0% (n=7/20) | 77.8% (n=7/9) | 100% (n=3/3) | 100% (n=1/1) | 0% (n=0/1) |
Serum LDL cholesterol (<2.5mmol/l) | 43.4% (n=29/67) | 47.4% (n=9/19) | 75.0% (n=6/8) | 100% (n=2/2) | 100% (n=1/1) | (n=0) |
NYHA class (similar or improved) | 83.9% (n=26/31) | 93.3% (n=14/15) | ||||
Target reached in at least one primary endpoint* | 47.8% (n=276/578) | 44.8% (n=125/279) | 49.5% (n=55/111) | 43.8% (n=28/64) | 75.5% (n=40/53) | 65.4% (n=17/26) |